TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
BVS

Bioventus Inc

Healthcare · Medical Devices

13.30$ +3.1% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Bioventus Inc (BVS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 153 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BVS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
121 135 129 151 139 154 124 148 139 158 132 153 582
42 49 41 48 45 51 42 47 46 50 42 48 186
79 86 88 104 94 103 81 101 93 107 90 106 396
3.0 3.3 2.6 4.2 3.8 3.2 3.0 3.2 2.9 3.0 2.5 3.2 12
70 75 78 95 81 87 74 79 79 83 78 83 322
76 85 83 135 89 95 76 82 81 86 81 87 334
2.4 1.2 4.9 -31 4.1 8.0 5.0 19 12 22 8.9 19 62
10 10 10 9.9 9.5 9.0 7.5 7.5 6.2 5.3 4.3 4.1 20
-8.2 -8.4 -5.5 -42 -4.8 0.2 -3.4 10 4.7 14 4.5 15 39
0.6 -0.8 0.9 -7.3 0.6 0.6 -0.1 1.0 0.7 -3.2 0.6 -21 -23
-7.3 -6.1 -4.9 -26 -4.8 -0.2 -2.6 7.5 3.2 15 3.1 33 54
16 14 17 -19 17 22 16 30 22 31 20 19 93

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?